Edition:
United States

Aegerion Pharmaceuticals Inc (AEGR.O)

AEGR.O on Nasdaq

1.97USD
29 Nov 2016
Change (% chg)

$0.10 (+5.35%)
Prev Close
$1.87
Open
$1.89
Day's High
$2.34
Day's Low
$1.86
Volume
2,168,985
Avg. Vol
--
52-wk High
--
52-wk Low
--

Select another date:

Tue, Nov 29 2016

BRIEF-Aegerion Pharmaceuticals issues $325 mln aggregate principal amount of 2.00% convertible senior notes

* Entered into a supplemental indenture to indenture dated August 15, 2014 -SEC filing

BRIEF-Armistice Capital reports 5.6 pct passive stake in Aegerion Pharmaceuticals

* Armistice Capital, Llc Reports 5.6 Pct Passive Stake In Aegerion Pharmaceuticals Inc as of Nov.7 Source text - http://bit.ly/2fYfgLP Further company coverage:

BRIEF-Aegerion Pharmaceuticals announces Q3 2016 financial results

* Aegerion Pharmaceuticals announces third quarter 2016 financial results

BRIEF-Aegerion pharmaceuticals to extend forbearance period

* On Sept 30, co amended forbearance deal dated Nov 9, 2015, to extend forbearance period through Nov 30, 2016 - SEC filing Source text for Eikon: Further company coverage:

BRIEF-Aegerion Pharmaceuticals' juxtapid capsules approved in Japan

* Aegerion pharmaceuticals' Juxtapid (Lomitapide) capsules approved in Japan for the treatment of homozygous Familial Hypercholesterolemia (HOFH)

BRIEF-Aegerion Pharmaceuticals announces Q2 2016 financial results

* Aegerion Pharmaceuticals announces second quarter 2016 financial results

BRIEF-Aegerion Pharmaceuticals unveils cost reduction plans

* Aegerion Pharmaceuticals says intends to withdraw lomitapide from european union (eu) and certain other global market Source text for Eikon: Further company coverage:

BRIEF-Aegerion pharmaceuticals, Qlt Inc agree to strategic merger

* Aegerion Pharmaceuticals and QLT Inc. agree to strategic merger

Select another date: